Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human cell surface triggers pp60src and Akt-GSK3 activities upstream and downstream to PI 3-kinase, respectively

被引:21
作者
Barel, M [1 ]
Balbo, M [1 ]
Le Romancer, M [1 ]
Frade, R [1 ]
机构
[1] INSERM, U354, Evry, France
关键词
B cell; proliferation; transformation; Epstein-Barr virus; C3d receptor;
D O I
10.1002/eji.200324059
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We previously demonstrated that CR2 activation on human B lymphocyte surface specifically triggered tyrosine phosphorylation of the 95-kDa nucleolin, this leading to its binding on SH2 domains of p85 sub-unit of PI 3-kinase and to activation of this enzyme. The specificity of CR2 pathway was clearly demonstrated as neither CD19 nor BCR could induce tyrosine phosphorylation of nucleolin in normal B lymphocytes. These data led us to investigate herein additional molecular events, which were triggered by CR2 activation, upstream and downstream to PI 3-kinase activation. Upstream, we demonstrated that pp60src, a tyrosine kinase of the src family, was involved in tyrosine phosphorylation of nucleolin, while syk tyrosine kinase was not. We also demonstrated a direct protein-protein interaction of pp60src with nucleolin in a CR2-dependent and CD19-independent pathway. Downstream, we demonstrated that CR2 activation also triggered Akt and GSK3 enzyme activation, this pathway being under the control of pp60src tyrosine kinase activation. These regulatory functions of activated CR2 were specific as independent of syk tyrosine kinase and of CD19 and BCR activation. Thus, CR2 activation recruits a specific mechanism to activate PI 3-kinase and its subsequent pathways, this mechanism being different to those recruited by CD19 and BCR.
引用
收藏
页码:2557 / 2566
页数:10
相关论文
共 31 条
  • [1] Pep34, a synthetic peptide whose sequence corresponds to the intracytoplasmic domain of the epstein-barr virus receptor (CR2, CD21), regulates human B lymphocyte proliferation triggered through CR2.
    Balbo, M
    Barel, M
    Bouillie, S
    Drane, P
    Cassinat, B
    Frade, R
    [J]. MOLECULAR IMMUNOLOGY, 1995, 32 (16) : 1295 - 1298
  • [2] Evidence for a new transcript of the Epstein-Barr virus C3d receptor (CR2, CD21) which is due to alternative exon usage
    Barel, M
    Balbo, M
    Frade, R
    [J]. MOLECULAR IMMUNOLOGY, 1998, 35 (16) : 1025 - 1031
  • [3] BAREL M, 1988, J IMMUNOL, V141, P1590
  • [4] GP-140, THE C3D/EBV RECEPTOR (CR-2), IS PHOSPHORYLATED UPON INVITRO ACTIVATION OF HUMAN PERIPHERAL LYMPHOCYTES-B
    BAREL, M
    VAZQUEZ, A
    CHARRIAUT, C
    AUFREDOU, MT
    GALANAUD, P
    FRADE, R
    [J]. FEBS LETTERS, 1986, 197 (1-2) : 353 - 356
  • [5] ISOLATION AND CHARACTERIZATION OF A C3B RECEPTOR-LIKE MOLECULE FROM MEMBRANES OF A HUMAN B-LYMPHOBLASTOID CELL-LINE (RAJI)
    BAREL, M
    CHARRIAUT, C
    FRADE, R
    [J]. FEBS LETTERS, 1981, 136 (01) : 111 - 114
  • [6] Activation of the EBV/C3d receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase
    Barel, M
    Le Romancer, M
    Frade, R
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (05) : 3167 - 3173
  • [7] SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling
    Beitz, LO
    Fruman, DA
    Kurosaki, T
    Cantley, LC
    Scharenberg, AM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (46) : 32662 - 32666
  • [8] BONNEFOY JY, 1993, EUR J IMMUNOL, V23, P969
  • [9] Bouillie S, 1999, J IMMUNOL, V162, P136
  • [10] BRADBURY LE, 1992, J IMMUNOL, V149, P2841